nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Conjugated Estrogens—osteoporosis	0.108	0.152	CbGbCtD
Pioglitazone—SLCO1B3—Estradiol—osteoporosis	0.0946	0.133	CbGbCtD
Pioglitazone—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0628	0.0884	CbGbCtD
Pioglitazone—SLCO1B1—Estradiol—osteoporosis	0.0551	0.0776	CbGbCtD
Pioglitazone—CYP2C9—Estropipate—osteoporosis	0.0392	0.0552	CbGbCtD
Pioglitazone—CYP2C8—Raloxifene—osteoporosis	0.0375	0.0528	CbGbCtD
Pioglitazone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0362	0.051	CbGbCtD
Pioglitazone—CYP2C8—Cholecalciferol—osteoporosis	0.0289	0.0408	CbGbCtD
Pioglitazone—CYP2C19—Cholecalciferol—osteoporosis	0.0243	0.0342	CbGbCtD
Pioglitazone—CYP2C8—Estradiol—osteoporosis	0.0233	0.0328	CbGbCtD
Pioglitazone—CYP3A4—Estropipate—osteoporosis	0.0228	0.0321	CbGbCtD
Pioglitazone—CYP3A4—Calcitriol—osteoporosis	0.0228	0.0321	CbGbCtD
Pioglitazone—CYP2C9—Cholecalciferol—osteoporosis	0.0202	0.0284	CbGbCtD
Pioglitazone—CYP2C19—Estradiol—osteoporosis	0.0196	0.0276	CbGbCtD
Pioglitazone—CYP2D6—Cholecalciferol—osteoporosis	0.0185	0.026	CbGbCtD
Pioglitazone—CYP3A4—Ergocalciferol—osteoporosis	0.0182	0.0256	CbGbCtD
Pioglitazone—CYP2C9—Estradiol—osteoporosis	0.0163	0.0229	CbGbCtD
Pioglitazone—CYP3A4—Raloxifene—osteoporosis	0.0152	0.0214	CbGbCtD
Pioglitazone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0147	0.0207	CbGbCtD
Pioglitazone—CYP3A4—Cholecalciferol—osteoporosis	0.0117	0.0165	CbGbCtD
Pioglitazone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0108	0.0152	CbGbCtD
Pioglitazone—CYP3A4—Estradiol—osteoporosis	0.00946	0.0133	CbGbCtD
Pioglitazone—Skin disorder—Raloxifene—osteoporosis	0.000344	0.00144	CcSEcCtD
Pioglitazone—Nervous system disorder—Ibandronate—osteoporosis	0.000344	0.00144	CcSEcCtD
Pioglitazone—Anaphylactic shock—Calcitriol—osteoporosis	0.000343	0.00144	CcSEcCtD
Pioglitazone—Back pain—Risedronate—osteoporosis	0.000343	0.00144	CcSEcCtD
Pioglitazone—Hyperhidrosis—Raloxifene—osteoporosis	0.000342	0.00144	CcSEcCtD
Pioglitazone—Skin disorder—Ibandronate—osteoporosis	0.000341	0.00143	CcSEcCtD
Pioglitazone—Muscle spasms—Risedronate—osteoporosis	0.00034	0.00143	CcSEcCtD
Pioglitazone—Influenza—Estradiol—osteoporosis	0.00034	0.00143	CcSEcCtD
Pioglitazone—Hyperhidrosis—Ibandronate—osteoporosis	0.000339	0.00142	CcSEcCtD
Pioglitazone—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000338	0.00142	CcSEcCtD
Pioglitazone—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000338	0.00142	CcSEcCtD
Pioglitazone—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000337	0.00142	CcSEcCtD
Pioglitazone—Malnutrition—Pamidronate—osteoporosis	0.000337	0.00141	CcSEcCtD
Pioglitazone—Urticaria—Etidronic acid—osteoporosis	0.000336	0.00141	CcSEcCtD
Pioglitazone—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000335	0.00141	CcSEcCtD
Pioglitazone—Skin disorder—Calcitriol—osteoporosis	0.000333	0.0014	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000333	0.0014	CcSEcCtD
Pioglitazone—Angioedema—Ethinyl Estradiol—osteoporosis	0.000332	0.00139	CcSEcCtD
Pioglitazone—Insomnia—Estropipate—osteoporosis	0.000331	0.00139	CcSEcCtD
Pioglitazone—Eye disorder—Zoledronate—osteoporosis	0.00033	0.00139	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000328	0.00138	CcSEcCtD
Pioglitazone—Cardiac disorder—Zoledronate—osteoporosis	0.000328	0.00138	CcSEcCtD
Pioglitazone—Visual impairment—Conjugated Estrogens—osteoporosis	0.000328	0.00138	CcSEcCtD
Pioglitazone—Malaise—Ethinyl Estradiol—osteoporosis	0.000328	0.00138	CcSEcCtD
Pioglitazone—Anaemia—Risedronate—osteoporosis	0.000327	0.00137	CcSEcCtD
Pioglitazone—Bronchitis—Estradiol—osteoporosis	0.000327	0.00137	CcSEcCtD
Pioglitazone—Back pain—Pamidronate—osteoporosis	0.000326	0.00137	CcSEcCtD
Pioglitazone—Muscle spasms—Pamidronate—osteoporosis	0.000324	0.00136	CcSEcCtD
Pioglitazone—Angioedema—Risedronate—osteoporosis	0.000324	0.00136	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000323	0.00136	CcSEcCtD
Pioglitazone—Insomnia—Raloxifene—osteoporosis	0.00032	0.00135	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00032	0.00134	CcSEcCtD
Pioglitazone—Immune system disorder—Zoledronate—osteoporosis	0.000319	0.00134	CcSEcCtD
Pioglitazone—Mediastinal disorder—Zoledronate—osteoporosis	0.000318	0.00134	CcSEcCtD
Pioglitazone—Vertigo—Risedronate—osteoporosis	0.000318	0.00134	CcSEcCtD
Pioglitazone—Eye disorder—Conjugated Estrogens—osteoporosis	0.000318	0.00133	CcSEcCtD
Pioglitazone—Insomnia—Ibandronate—osteoporosis	0.000317	0.00133	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Estradiol—osteoporosis	0.000316	0.00133	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Estropipate—osteoporosis	0.000316	0.00133	CcSEcCtD
Pioglitazone—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000316	0.00133	CcSEcCtD
Pioglitazone—Fatigue—Estropipate—osteoporosis	0.000315	0.00132	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000313	0.00131	CcSEcCtD
Pioglitazone—Ill-defined disorder—Pamidronate—osteoporosis	0.000312	0.00131	CcSEcCtD
Pioglitazone—Hypersensitivity—Etidronic acid—osteoporosis	0.000311	0.00131	CcSEcCtD
Pioglitazone—Anaemia—Pamidronate—osteoporosis	0.000311	0.00131	CcSEcCtD
Pioglitazone—Insomnia—Calcitriol—osteoporosis	0.000311	0.0013	CcSEcCtD
Pioglitazone—Weight increased—Estradiol—osteoporosis	0.00031	0.0013	CcSEcCtD
Pioglitazone—Weight decreased—Estradiol—osteoporosis	0.000308	0.00129	CcSEcCtD
Pioglitazone—Angioedema—Pamidronate—osteoporosis	0.000308	0.00129	CcSEcCtD
Pioglitazone—Malnutrition—Zoledronate—osteoporosis	0.000308	0.00129	CcSEcCtD
Pioglitazone—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000307	0.00129	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000307	0.00129	CcSEcCtD
Pioglitazone—Hyperglycaemia—Estradiol—osteoporosis	0.000307	0.00129	CcSEcCtD
Pioglitazone—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000307	0.00129	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000306	0.00128	CcSEcCtD
Pioglitazone—Hypertension—Risedronate—osteoporosis	0.000306	0.00128	CcSEcCtD
Pioglitazone—Discomfort—Ethinyl Estradiol—osteoporosis	0.000306	0.00128	CcSEcCtD
Pioglitazone—Malaise—Pamidronate—osteoporosis	0.000304	0.00127	CcSEcCtD
Pioglitazone—Infestation—Estradiol—osteoporosis	0.000303	0.00127	CcSEcCtD
Pioglitazone—Infestation NOS—Estradiol—osteoporosis	0.000303	0.00127	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000303	0.00127	CcSEcCtD
Pioglitazone—Fatigue—Ibandronate—osteoporosis	0.000302	0.00127	CcSEcCtD
Pioglitazone—Arthralgia—Risedronate—osteoporosis	0.000301	0.00127	CcSEcCtD
Pioglitazone—Chest pain—Risedronate—osteoporosis	0.000301	0.00127	CcSEcCtD
Pioglitazone—Myalgia—Risedronate—osteoporosis	0.000301	0.00127	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000299	0.00126	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Estradiol—osteoporosis	0.000299	0.00126	CcSEcCtD
Pioglitazone—Back pain—Zoledronate—osteoporosis	0.000297	0.00125	CcSEcCtD
Pioglitazone—Myocardial infarction—Estradiol—osteoporosis	0.000297	0.00125	CcSEcCtD
Pioglitazone—Feeling abnormal—Alendronate—osteoporosis	0.000297	0.00125	CcSEcCtD
Pioglitazone—Oedema—Ethinyl Estradiol—osteoporosis	0.000296	0.00124	CcSEcCtD
Pioglitazone—Malnutrition—Conjugated Estrogens—osteoporosis	0.000296	0.00124	CcSEcCtD
Pioglitazone—Muscle spasms—Zoledronate—osteoporosis	0.000296	0.00124	CcSEcCtD
Pioglitazone—Urinary tract infection—Estradiol—osteoporosis	0.000295	0.00124	CcSEcCtD
Pioglitazone—Infection—Ethinyl Estradiol—osteoporosis	0.000295	0.00124	CcSEcCtD
Pioglitazone—Flatulence—Conjugated Estrogens—osteoporosis	0.000292	0.00123	CcSEcCtD
Pioglitazone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000291	0.00122	CcSEcCtD
Pioglitazone—Hypertension—Pamidronate—osteoporosis	0.000291	0.00122	CcSEcCtD
Pioglitazone—Urticaria—Estropipate—osteoporosis	0.000291	0.00122	CcSEcCtD
Pioglitazone—Diarrhoea—Etidronic acid—osteoporosis	0.000289	0.00121	CcSEcCtD
Pioglitazone—Haematuria—Estradiol—osteoporosis	0.000289	0.00121	CcSEcCtD
Pioglitazone—Feeling abnormal—Ibandronate—osteoporosis	0.000289	0.00121	CcSEcCtD
Pioglitazone—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000288	0.00121	CcSEcCtD
Pioglitazone—Infection—Risedronate—osteoporosis	0.000287	0.00121	CcSEcCtD
Pioglitazone—Arthralgia—Pamidronate—osteoporosis	0.000287	0.0012	CcSEcCtD
Pioglitazone—Myalgia—Pamidronate—osteoporosis	0.000287	0.0012	CcSEcCtD
Pioglitazone—Back pain—Conjugated Estrogens—osteoporosis	0.000286	0.0012	CcSEcCtD
Pioglitazone—Urticaria—Alendronate—osteoporosis	0.000286	0.0012	CcSEcCtD
Pioglitazone—Ill-defined disorder—Zoledronate—osteoporosis	0.000285	0.0012	CcSEcCtD
Pioglitazone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000285	0.0012	CcSEcCtD
Pioglitazone—Sinusitis—Estradiol—osteoporosis	0.000284	0.00119	CcSEcCtD
Pioglitazone—Anaemia—Zoledronate—osteoporosis	0.000284	0.00119	CcSEcCtD
Pioglitazone—Nervous system disorder—Risedronate—osteoporosis	0.000283	0.00119	CcSEcCtD
Pioglitazone—Discomfort—Pamidronate—osteoporosis	0.000283	0.00119	CcSEcCtD
Pioglitazone—Angioedema—Zoledronate—osteoporosis	0.000281	0.00118	CcSEcCtD
Pioglitazone—Skin disorder—Risedronate—osteoporosis	0.000281	0.00118	CcSEcCtD
Pioglitazone—Urticaria—Ibandronate—osteoporosis	0.000279	0.00117	CcSEcCtD
Pioglitazone—Malaise—Zoledronate—osteoporosis	0.000277	0.00116	CcSEcCtD
Pioglitazone—Vertigo—Zoledronate—osteoporosis	0.000276	0.00116	CcSEcCtD
Pioglitazone—Oedema—Pamidronate—osteoporosis	0.000275	0.00115	CcSEcCtD
Pioglitazone—Anaphylactic shock—Pamidronate—osteoporosis	0.000275	0.00115	CcSEcCtD
Pioglitazone—Infection—Pamidronate—osteoporosis	0.000273	0.00115	CcSEcCtD
Pioglitazone—Urticaria—Calcitriol—osteoporosis	0.000273	0.00115	CcSEcCtD
Pioglitazone—Hepatitis—Estradiol—osteoporosis	0.000272	0.00114	CcSEcCtD
Pioglitazone—Hypoaesthesia—Estradiol—osteoporosis	0.000271	0.00114	CcSEcCtD
Pioglitazone—Angioedema—Conjugated Estrogens—osteoporosis	0.000271	0.00114	CcSEcCtD
Pioglitazone—Pharyngitis—Estradiol—osteoporosis	0.00027	0.00113	CcSEcCtD
Pioglitazone—Hypersensitivity—Estropipate—osteoporosis	0.000269	0.00113	CcSEcCtD
Pioglitazone—Nervous system disorder—Pamidronate—osteoporosis	0.000269	0.00113	CcSEcCtD
Pioglitazone—Urinary tract disorder—Estradiol—osteoporosis	0.000269	0.00113	CcSEcCtD
Pioglitazone—Oedema peripheral—Estradiol—osteoporosis	0.000268	0.00113	CcSEcCtD
Pioglitazone—Connective tissue disorder—Estradiol—osteoporosis	0.000268	0.00112	CcSEcCtD
Pioglitazone—Urethral disorder—Estradiol—osteoporosis	0.000267	0.00112	CcSEcCtD
Pioglitazone—Vertigo—Conjugated Estrogens—osteoporosis	0.000266	0.00112	CcSEcCtD
Pioglitazone—Hyperhidrosis—Pamidronate—osteoporosis	0.000266	0.00112	CcSEcCtD
Pioglitazone—Hypertension—Zoledronate—osteoporosis	0.000265	0.00111	CcSEcCtD
Pioglitazone—Hypersensitivity—Alendronate—osteoporosis	0.000265	0.00111	CcSEcCtD
Pioglitazone—Headache—Etidronic acid—osteoporosis	0.000265	0.00111	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000263	0.00111	CcSEcCtD
Pioglitazone—Asthenia—Estropipate—osteoporosis	0.000262	0.0011	CcSEcCtD
Pioglitazone—Visual impairment—Estradiol—osteoporosis	0.000262	0.0011	CcSEcCtD
Pioglitazone—Arthralgia—Zoledronate—osteoporosis	0.000262	0.0011	CcSEcCtD
Pioglitazone—Chest pain—Zoledronate—osteoporosis	0.000262	0.0011	CcSEcCtD
Pioglitazone—Myalgia—Zoledronate—osteoporosis	0.000262	0.0011	CcSEcCtD
Pioglitazone—Insomnia—Risedronate—osteoporosis	0.000261	0.0011	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00026	0.00109	CcSEcCtD
Pioglitazone—Discomfort—Zoledronate—osteoporosis	0.000259	0.00109	CcSEcCtD
Pioglitazone—Asthenia—Alendronate—osteoporosis	0.000258	0.00109	CcSEcCtD
Pioglitazone—Hypersensitivity—Ibandronate—osteoporosis	0.000258	0.00109	CcSEcCtD
Pioglitazone—Dyspnoea—Risedronate—osteoporosis	0.000258	0.00108	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000256	0.00107	CcSEcCtD
Pioglitazone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000256	0.00107	CcSEcCtD
Pioglitazone—Eye disorder—Estradiol—osteoporosis	0.000254	0.00107	CcSEcCtD
Pioglitazone—Hypersensitivity—Calcitriol—osteoporosis	0.000253	0.00106	CcSEcCtD
Pioglitazone—Cardiac disorder—Estradiol—osteoporosis	0.000253	0.00106	CcSEcCtD
Pioglitazone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000252	0.00106	CcSEcCtD
Pioglitazone—Myalgia—Conjugated Estrogens—osteoporosis	0.000252	0.00106	CcSEcCtD
Pioglitazone—Chest pain—Conjugated Estrogens—osteoporosis	0.000252	0.00106	CcSEcCtD
Pioglitazone—Asthenia—Ibandronate—osteoporosis	0.000252	0.00106	CcSEcCtD
Pioglitazone—Oedema—Zoledronate—osteoporosis	0.000251	0.00105	CcSEcCtD
Pioglitazone—Anaphylactic shock—Zoledronate—osteoporosis	0.000251	0.00105	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00025	0.00105	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00025	0.00105	CcSEcCtD
Pioglitazone—Diarrhoea—Estropipate—osteoporosis	0.00025	0.00105	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Risedronate—osteoporosis	0.00025	0.00105	CcSEcCtD
Pioglitazone—Infection—Zoledronate—osteoporosis	0.000249	0.00105	CcSEcCtD
Pioglitazone—Fatigue—Risedronate—osteoporosis	0.000249	0.00105	CcSEcCtD
Pioglitazone—Insomnia—Pamidronate—osteoporosis	0.000249	0.00104	CcSEcCtD
Pioglitazone—Diarrhoea—Alendronate—osteoporosis	0.000246	0.00103	CcSEcCtD
Pioglitazone—Asthenia—Calcitriol—osteoporosis	0.000246	0.00103	CcSEcCtD
Pioglitazone—Nervous system disorder—Zoledronate—osteoporosis	0.000246	0.00103	CcSEcCtD
Pioglitazone—Immune system disorder—Estradiol—osteoporosis	0.000246	0.00103	CcSEcCtD
Pioglitazone—Mediastinal disorder—Estradiol—osteoporosis	0.000245	0.00103	CcSEcCtD
Pioglitazone—Dyspnoea—Pamidronate—osteoporosis	0.000245	0.00103	CcSEcCtD
Pioglitazone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000244	0.00103	CcSEcCtD
Pioglitazone—Skin disorder—Zoledronate—osteoporosis	0.000244	0.00102	CcSEcCtD
Pioglitazone—Hyperhidrosis—Zoledronate—osteoporosis	0.000243	0.00102	CcSEcCtD
Pioglitazone—Diarrhoea—Raloxifene—osteoporosis	0.000242	0.00102	CcSEcCtD
Pioglitazone—Dizziness—Estropipate—osteoporosis	0.000242	0.00102	CcSEcCtD
Pioglitazone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000242	0.00101	CcSEcCtD
Pioglitazone—Oedema—Conjugated Estrogens—osteoporosis	0.000242	0.00101	CcSEcCtD
Pioglitazone—Infection—Conjugated Estrogens—osteoporosis	0.00024	0.00101	CcSEcCtD
Pioglitazone—Diarrhoea—Ibandronate—osteoporosis	0.00024	0.00101	CcSEcCtD
Pioglitazone—Dizziness—Alendronate—osteoporosis	0.000238	0.001	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000237	0.000996	CcSEcCtD
Pioglitazone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000237	0.000995	CcSEcCtD
Pioglitazone—Malnutrition—Estradiol—osteoporosis	0.000237	0.000995	CcSEcCtD
Pioglitazone—Fatigue—Pamidronate—osteoporosis	0.000237	0.000995	CcSEcCtD
Pioglitazone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000235	0.000989	CcSEcCtD
Pioglitazone—Diarrhoea—Calcitriol—osteoporosis	0.000235	0.000986	CcSEcCtD
Pioglitazone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000235	0.000986	CcSEcCtD
Pioglitazone—Dizziness—Raloxifene—osteoporosis	0.000234	0.000984	CcSEcCtD
Pioglitazone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000234	0.000981	CcSEcCtD
Pioglitazone—Flatulence—Estradiol—osteoporosis	0.000234	0.000981	CcSEcCtD
Pioglitazone—Dizziness—Ibandronate—osteoporosis	0.000232	0.000974	CcSEcCtD
Pioglitazone—Urticaria—Risedronate—osteoporosis	0.00023	0.000964	CcSEcCtD
Pioglitazone—Back pain—Estradiol—osteoporosis	0.000229	0.000963	CcSEcCtD
Pioglitazone—Headache—Estropipate—osteoporosis	0.000229	0.000962	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000229	0.00096	CcSEcCtD
Pioglitazone—Muscle spasms—Estradiol—osteoporosis	0.000228	0.000957	CcSEcCtD
Pioglitazone—Insomnia—Zoledronate—osteoporosis	0.000227	0.000953	CcSEcCtD
Pioglitazone—Feeling abnormal—Pamidronate—osteoporosis	0.000226	0.000951	CcSEcCtD
Pioglitazone—Headache—Alendronate—osteoporosis	0.000226	0.000948	CcSEcCtD
Pioglitazone—Dyspnoea—Zoledronate—osteoporosis	0.000224	0.00094	CcSEcCtD
Pioglitazone—Headache—Raloxifene—osteoporosis	0.000222	0.000932	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00022	0.000925	CcSEcCtD
Pioglitazone—Ill-defined disorder—Estradiol—osteoporosis	0.00022	0.000923	CcSEcCtD
Pioglitazone—Headache—Ibandronate—osteoporosis	0.00022	0.000923	CcSEcCtD
Pioglitazone—Insomnia—Conjugated Estrogens—osteoporosis	0.000219	0.000918	CcSEcCtD
Pioglitazone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000218	0.000917	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000217	0.00091	CcSEcCtD
Pioglitazone—Angioedema—Estradiol—osteoporosis	0.000217	0.000909	CcSEcCtD
Pioglitazone—Fatigue—Zoledronate—osteoporosis	0.000216	0.000909	CcSEcCtD
Pioglitazone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000215	0.000905	CcSEcCtD
Pioglitazone—Headache—Calcitriol—osteoporosis	0.000215	0.000903	CcSEcCtD
Pioglitazone—Malaise—Estradiol—osteoporosis	0.000214	0.000897	CcSEcCtD
Pioglitazone—Hypersensitivity—Risedronate—osteoporosis	0.000213	0.000894	CcSEcCtD
Pioglitazone—Vertigo—Estradiol—osteoporosis	0.000213	0.000894	CcSEcCtD
Pioglitazone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000213	0.000893	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000209	0.000876	CcSEcCtD
Pioglitazone—Fatigue—Conjugated Estrogens—osteoporosis	0.000208	0.000875	CcSEcCtD
Pioglitazone—Asthenia—Risedronate—osteoporosis	0.000207	0.000871	CcSEcCtD
Pioglitazone—Feeling abnormal—Zoledronate—osteoporosis	0.000207	0.000868	CcSEcCtD
Pioglitazone—Hypertension—Estradiol—osteoporosis	0.000205	0.000859	CcSEcCtD
Pioglitazone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000203	0.000852	CcSEcCtD
Pioglitazone—Hypersensitivity—Pamidronate—osteoporosis	0.000202	0.00085	CcSEcCtD
Pioglitazone—Chest pain—Estradiol—osteoporosis	0.000202	0.000847	CcSEcCtD
Pioglitazone—Myalgia—Estradiol—osteoporosis	0.000202	0.000847	CcSEcCtD
Pioglitazone—Arthralgia—Estradiol—osteoporosis	0.000202	0.000847	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.0002	0.000841	CcSEcCtD
Pioglitazone—Urticaria—Zoledronate—osteoporosis	0.000199	0.000837	CcSEcCtD
Pioglitazone—Discomfort—Estradiol—osteoporosis	0.000199	0.000837	CcSEcCtD
Pioglitazone—Diarrhoea—Risedronate—osteoporosis	0.000198	0.00083	CcSEcCtD
Pioglitazone—Asthenia—Pamidronate—osteoporosis	0.000197	0.000828	CcSEcCtD
Pioglitazone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000196	0.000823	CcSEcCtD
Pioglitazone—Oedema—Estradiol—osteoporosis	0.000193	0.000812	CcSEcCtD
Pioglitazone—Anaphylactic shock—Estradiol—osteoporosis	0.000193	0.000812	CcSEcCtD
Pioglitazone—Infection—Estradiol—osteoporosis	0.000192	0.000807	CcSEcCtD
Pioglitazone—Urticaria—Conjugated Estrogens—osteoporosis	0.000192	0.000806	CcSEcCtD
Pioglitazone—Dizziness—Risedronate—osteoporosis	0.000191	0.000803	CcSEcCtD
Pioglitazone—Nervous system disorder—Estradiol—osteoporosis	0.00019	0.000796	CcSEcCtD
Pioglitazone—Diarrhoea—Pamidronate—osteoporosis	0.000188	0.000789	CcSEcCtD
Pioglitazone—Skin disorder—Estradiol—osteoporosis	0.000188	0.000789	CcSEcCtD
Pioglitazone—Hyperhidrosis—Estradiol—osteoporosis	0.000187	0.000785	CcSEcCtD
Pioglitazone—Headache—Ethinyl Estradiol—osteoporosis	0.000186	0.00078	CcSEcCtD
Pioglitazone—Hypersensitivity—Zoledronate—osteoporosis	0.000185	0.000776	CcSEcCtD
Pioglitazone—Dizziness—Pamidronate—osteoporosis	0.000182	0.000763	CcSEcCtD
Pioglitazone—Headache—Risedronate—osteoporosis	0.000181	0.00076	CcSEcCtD
Pioglitazone—Asthenia—Zoledronate—osteoporosis	0.00018	0.000756	CcSEcCtD
Pioglitazone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000178	0.000748	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000176	0.00074	CcSEcCtD
Pioglitazone—Insomnia—Estradiol—osteoporosis	0.000175	0.000735	CcSEcCtD
Pioglitazone—Asthenia—Conjugated Estrogens—osteoporosis	0.000173	0.000728	CcSEcCtD
Pioglitazone—Dyspnoea—Estradiol—osteoporosis	0.000172	0.000724	CcSEcCtD
Pioglitazone—Headache—Pamidronate—osteoporosis	0.000172	0.000723	CcSEcCtD
Pioglitazone—Diarrhoea—Zoledronate—osteoporosis	0.000172	0.000721	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000167	0.000701	CcSEcCtD
Pioglitazone—Fatigue—Estradiol—osteoporosis	0.000167	0.0007	CcSEcCtD
Pioglitazone—Dizziness—Zoledronate—osteoporosis	0.000166	0.000697	CcSEcCtD
Pioglitazone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000165	0.000694	CcSEcCtD
Pioglitazone—Dizziness—Conjugated Estrogens—osteoporosis	0.00016	0.000671	CcSEcCtD
Pioglitazone—Feeling abnormal—Estradiol—osteoporosis	0.000159	0.000669	CcSEcCtD
Pioglitazone—Headache—Zoledronate—osteoporosis	0.000157	0.00066	CcSEcCtD
Pioglitazone—Urticaria—Estradiol—osteoporosis	0.000154	0.000645	CcSEcCtD
Pioglitazone—Headache—Conjugated Estrogens—osteoporosis	0.000151	0.000636	CcSEcCtD
Pioglitazone—Hypersensitivity—Estradiol—osteoporosis	0.000142	0.000598	CcSEcCtD
Pioglitazone—Asthenia—Estradiol—osteoporosis	0.000139	0.000583	CcSEcCtD
Pioglitazone—Diarrhoea—Estradiol—osteoporosis	0.000132	0.000556	CcSEcCtD
Pioglitazone—Dizziness—Estradiol—osteoporosis	0.000128	0.000537	CcSEcCtD
Pioglitazone—Headache—Estradiol—osteoporosis	0.000121	0.000509	CcSEcCtD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.13e-05	0.00118	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP27A1—osteoporosis	6.09e-05	0.00118	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.05e-05	0.00117	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GPD2—osteoporosis	6.01e-05	0.00116	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PGLS—osteoporosis	6.01e-05	0.00116	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	5.93e-05	0.00115	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ACP5—osteoporosis	5.93e-05	0.00114	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.9e-05	0.00114	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	5.88e-05	0.00114	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.85e-05	0.00113	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	5.85e-05	0.00113	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	5.8e-05	0.00112	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.58e-05	0.00108	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—IDH2—osteoporosis	5.53e-05	0.00107	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.52e-05	0.00107	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—TPI1—osteoporosis	5.51e-05	0.00106	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ATIC—osteoporosis	5.5e-05	0.00106	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PNP—osteoporosis	5.5e-05	0.00106	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.41e-05	0.00105	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.38e-05	0.00104	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.28e-05	0.00102	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CA2—osteoporosis	5.25e-05	0.00101	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—OXCT1—osteoporosis	5.25e-05	0.00101	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IL6—osteoporosis	5.22e-05	0.00101	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP27A1—osteoporosis	5.2e-05	0.001	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—P4HB—osteoporosis	5.18e-05	0.001	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—MGLL—osteoporosis	5.12e-05	0.000989	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GAPDH—osteoporosis	5.09e-05	0.000982	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ACP5—osteoporosis	5.06e-05	0.000976	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	4.99e-05	0.000964	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.99e-05	0.000964	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—RAP1A—osteoporosis	4.95e-05	0.000956	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—ESR1—osteoporosis	4.87e-05	0.000941	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.83e-05	0.000932	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—LEP—osteoporosis	4.8e-05	0.000927	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.71e-05	0.00091	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—TPI1—osteoporosis	4.7e-05	0.000908	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CA2—osteoporosis	4.67e-05	0.000903	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—OXCT1—osteoporosis	4.67e-05	0.000903	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MGLL—osteoporosis	4.56e-05	0.00088	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.49e-05	0.000867	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—P4HB—osteoporosis	4.42e-05	0.000853	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.39e-05	0.000847	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—IDH2—osteoporosis	4.35e-05	0.000841	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—POMC—osteoporosis	4.34e-05	0.000838	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GAPDH—osteoporosis	4.34e-05	0.000838	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PSMA2—osteoporosis	4.33e-05	0.000836	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PSMA5—osteoporosis	4.33e-05	0.000836	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.32e-05	0.000834	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.3e-05	0.00083	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.3e-05	0.000829	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—RAP1A—osteoporosis	4.23e-05	0.000816	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PKM—osteoporosis	4.1e-05	0.000791	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—FDPS—osteoporosis	4.1e-05	0.000791	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP27A1—osteoporosis	4.09e-05	0.00079	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6R—osteoporosis	4.03e-05	0.000777	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.01e-05	0.000774	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ENO1—osteoporosis	4e-05	0.000773	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ACP5—osteoporosis	3.98e-05	0.000769	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PSMA5—osteoporosis	3.95e-05	0.000762	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PSMA2—osteoporosis	3.95e-05	0.000762	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.93e-05	0.000759	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PGLS—osteoporosis	3.88e-05	0.00075	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPD2—osteoporosis	3.88e-05	0.00075	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.88e-05	0.000749	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—POMC—osteoporosis	3.88e-05	0.000748	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—IDH2—osteoporosis	3.87e-05	0.000748	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ESR2—osteoporosis	3.87e-05	0.000747	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.83e-05	0.000739	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.75e-05	0.000724	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—TPI1—osteoporosis	3.7e-05	0.000715	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.69e-05	0.000712	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—IL6—osteoporosis	3.68e-05	0.000711	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PKM—osteoporosis	3.66e-05	0.000706	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—FDPS—osteoporosis	3.66e-05	0.000706	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.66e-05	0.000706	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP27A1—osteoporosis	3.64e-05	0.000703	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—POMC—osteoporosis	3.57e-05	0.000688	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ATIC—osteoporosis	3.55e-05	0.000686	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PNP—osteoporosis	3.55e-05	0.000686	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ACP5—osteoporosis	3.54e-05	0.000684	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—POMC—osteoporosis	3.53e-05	0.000682	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.5e-05	0.000675	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—P4HB—osteoporosis	3.48e-05	0.000672	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPD2—osteoporosis	3.47e-05	0.000669	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PGLS—osteoporosis	3.47e-05	0.000669	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GAPDH—osteoporosis	3.42e-05	0.00066	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ENO1—osteoporosis	3.42e-05	0.00066	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PSMA2—osteoporosis	3.37e-05	0.00065	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PSMA5—osteoporosis	3.37e-05	0.00065	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PKM—osteoporosis	3.36e-05	0.000649	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—FDPS—osteoporosis	3.36e-05	0.000649	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—FDPS—osteoporosis	3.33e-05	0.000644	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PKM—osteoporosis	3.33e-05	0.000644	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—RAP1A—osteoporosis	3.33e-05	0.000643	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—TPI1—osteoporosis	3.29e-05	0.000636	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP19A1—osteoporosis	3.2e-05	0.000618	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPD2—osteoporosis	3.19e-05	0.000615	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PGLS—osteoporosis	3.19e-05	0.000615	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ATIC—osteoporosis	3.17e-05	0.000612	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PNP—osteoporosis	3.17e-05	0.000612	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PGLS—osteoporosis	3.16e-05	0.00061	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPD2—osteoporosis	3.16e-05	0.00061	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—P4HB—osteoporosis	3.1e-05	0.000598	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—VDR—osteoporosis	3.07e-05	0.000593	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GAPDH—osteoporosis	3.04e-05	0.000587	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—OXCT1—osteoporosis	3.02e-05	0.000583	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CA2—osteoporosis	3.02e-05	0.000583	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—RAP1A—osteoporosis	2.96e-05	0.000572	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MGLL—osteoporosis	2.94e-05	0.000568	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PNP—osteoporosis	2.92e-05	0.000563	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ATIC—osteoporosis	2.92e-05	0.000563	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.9e-05	0.00056	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PNP—osteoporosis	2.89e-05	0.000558	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ATIC—osteoporosis	2.89e-05	0.000558	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.77e-05	0.000536	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP19A1—osteoporosis	2.73e-05	0.000527	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—OXCT1—osteoporosis	2.7e-05	0.00052	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CA2—osteoporosis	2.7e-05	0.00052	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ENO1—osteoporosis	2.69e-05	0.000519	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PSMA2—osteoporosis	2.65e-05	0.000512	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PSMA5—osteoporosis	2.65e-05	0.000512	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MGLL—osteoporosis	2.63e-05	0.000507	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ADCY5—osteoporosis	2.62e-05	0.000505	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GPX1—osteoporosis	2.61e-05	0.000503	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.58e-05	0.000498	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—MYC—osteoporosis	2.53e-05	0.000489	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—IDH2—osteoporosis	2.5e-05	0.000483	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—OXCT1—osteoporosis	2.48e-05	0.000479	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CA2—osteoporosis	2.48e-05	0.000479	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.48e-05	0.000478	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—OXCT1—osteoporosis	2.46e-05	0.000474	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CA2—osteoporosis	2.46e-05	0.000474	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MGLL—osteoporosis	2.42e-05	0.000466	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—MTHFR—osteoporosis	2.41e-05	0.000464	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MGLL—osteoporosis	2.39e-05	0.000462	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ENO1—osteoporosis	2.39e-05	0.000462	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TGFB1—osteoporosis	2.38e-05	0.000459	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PSMA2—osteoporosis	2.36e-05	0.000455	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PSMA5—osteoporosis	2.36e-05	0.000455	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.35e-05	0.000454	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ESR1—osteoporosis	2.35e-05	0.000453	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—POMC—osteoporosis	2.33e-05	0.00045	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ACP5—osteoporosis	2.29e-05	0.000442	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.26e-05	0.000436	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.26e-05	0.000436	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—IDH2—osteoporosis	2.23e-05	0.000431	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ADCY5—osteoporosis	2.23e-05	0.000431	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GPX1—osteoporosis	2.22e-05	0.000429	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TNF—osteoporosis	2.22e-05	0.000429	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PKM—osteoporosis	2.2e-05	0.000424	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FDPS—osteoporosis	2.2e-05	0.000424	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP19A1—osteoporosis	2.15e-05	0.000415	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TPI1—osteoporosis	2.13e-05	0.000411	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.1e-05	0.000405	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPD2—osteoporosis	2.08e-05	0.000402	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PGLS—osteoporosis	2.08e-05	0.000402	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—IDH2—osteoporosis	2.05e-05	0.000397	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—MTHFR—osteoporosis	2.05e-05	0.000396	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ACP5—osteoporosis	2.04e-05	0.000394	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—IDH2—osteoporosis	2.04e-05	0.000393	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.02e-05	0.000389	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—P4HB—osteoporosis	2e-05	0.000386	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GAPDH—osteoporosis	1.96e-05	0.000379	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.93e-05	0.000373	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—POMC—osteoporosis	1.92e-05	0.000371	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.91e-05	0.00037	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP19A1—osteoporosis	1.91e-05	0.000369	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—RAP1A—osteoporosis	1.91e-05	0.000369	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ATIC—osteoporosis	1.91e-05	0.000368	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PNP—osteoporosis	1.91e-05	0.000368	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TPI1—osteoporosis	1.9e-05	0.000367	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ACP5—osteoporosis	1.88e-05	0.000363	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ACP5—osteoporosis	1.86e-05	0.00036	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.84e-05	0.000355	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—osteoporosis	1.79e-05	0.000346	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—P4HB—osteoporosis	1.79e-05	0.000345	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ADCY5—osteoporosis	1.76e-05	0.000339	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GAPDH—osteoporosis	1.75e-05	0.000338	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GPX1—osteoporosis	1.75e-05	0.000338	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TPI1—osteoporosis	1.75e-05	0.000337	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TPI1—osteoporosis	1.73e-05	0.000334	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—RAP1A—osteoporosis	1.71e-05	0.00033	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.67e-05	0.000322	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—P4HB—osteoporosis	1.64e-05	0.000317	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—POMC—osteoporosis	1.64e-05	0.000317	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—P4HB—osteoporosis	1.63e-05	0.000314	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—OXCT1—osteoporosis	1.62e-05	0.000313	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CA2—osteoporosis	1.62e-05	0.000313	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—MTHFR—osteoporosis	1.62e-05	0.000312	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GAPDH—osteoporosis	1.61e-05	0.000311	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GAPDH—osteoporosis	1.6e-05	0.000309	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MGLL—osteoporosis	1.58e-05	0.000305	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—RAP1A—osteoporosis	1.57e-05	0.000303	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ADCY5—osteoporosis	1.56e-05	0.000302	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GPX1—osteoporosis	1.56e-05	0.000301	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—RAP1A—osteoporosis	1.56e-05	0.0003	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ENO1—osteoporosis	1.55e-05	0.000298	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PSMA2—osteoporosis	1.52e-05	0.000294	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PSMA5—osteoporosis	1.52e-05	0.000294	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.49e-05	0.000287	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MTHFR—osteoporosis	1.44e-05	0.000278	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ENO1—osteoporosis	1.38e-05	0.000266	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMA2—osteoporosis	1.36e-05	0.000262	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMA5—osteoporosis	1.36e-05	0.000262	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.36e-05	0.000262	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—IDH2—osteoporosis	1.34e-05	0.000259	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—POMC—osteoporosis	1.29e-05	0.00025	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ENO1—osteoporosis	1.27e-05	0.000245	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.26e-05	0.000244	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ENO1—osteoporosis	1.26e-05	0.000243	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.25e-05	0.000241	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.25e-05	0.000241	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMA5—osteoporosis	1.24e-05	0.000239	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMA2—osteoporosis	1.24e-05	0.000239	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.24e-05	0.000239	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ACP5—osteoporosis	1.23e-05	0.000237	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—osteoporosis	1.22e-05	0.000236	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—POMC—osteoporosis	1.15e-05	0.000222	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TPI1—osteoporosis	1.14e-05	0.00022	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.1e-05	0.000213	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—P4HB—osteoporosis	1.07e-05	0.000207	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.05e-05	0.000203	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.03e-05	0.000198	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.01e-05	0.000196	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ADCY5—osteoporosis	1.01e-05	0.000195	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPX1—osteoporosis	1.01e-05	0.000194	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.01e-05	0.000194	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—osteoporosis	9.29e-06	0.000179	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADCY5—osteoporosis	9.01e-06	0.000174	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPX1—osteoporosis	8.98e-06	0.000173	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ENO1—osteoporosis	8.3e-06	0.00016	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADCY5—osteoporosis	8.29e-06	0.00016	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—osteoporosis	8.29e-06	0.00016	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPX1—osteoporosis	8.26e-06	0.000159	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADCY5—osteoporosis	8.22e-06	0.000159	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPX1—osteoporosis	8.19e-06	0.000158	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMA2—osteoporosis	8.18e-06	0.000158	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMA5—osteoporosis	8.18e-06	0.000158	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—osteoporosis	7.62e-06	0.000147	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—osteoporosis	7.56e-06	0.000146	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—POMC—osteoporosis	7.43e-06	0.000143	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.63e-06	0.000128	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—POMC—osteoporosis	6.63e-06	0.000128	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—POMC—osteoporosis	6.1e-06	0.000118	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—POMC—osteoporosis	6.04e-06	0.000117	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADCY5—osteoporosis	5.42e-06	0.000105	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX1—osteoporosis	5.4e-06	0.000104	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.98e-06	9.62e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—POMC—osteoporosis	3.99e-06	7.7e-05	CbGpPWpGaD
